cyclopentane has been researched along with Nervous System Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rammes, G; Schierloh, A | 1 |
| Althaus, M; Hanschmann, A; Klein, T; Magerl, W; Treede, RD | 1 |
| Braitman, DJ; Brennecke, LH; Sparenborg, S | 1 |
1 review(s) available for cyclopentane and Nervous System Disorders
| Article | Year |
|---|---|
Neramexane (merz pharmaceuticals/forest laboratories).
Topics: Animals; Clinical Trials as Topic; Cyclopentanes; Humans; Nervous System Diseases; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2006 |
1 trial(s) available for cyclopentane and Nervous System Disorders
| Article | Year |
|---|---|
Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
Topics: Aminopyridines; Analgesics; Capsaicin; Cross-Over Studies; Cyclopentanes; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hyperalgesia; Injections, Intradermal; Nervous System Diseases; Pain; Physical Stimulation; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2008 |
1 other study(ies) available for cyclopentane and Nervous System Disorders
| Article | Year |
|---|---|
Prevention of soman neurotoxicity by non-opioid antitussives.
Topics: Animals; Anticonvulsants; Antitussive Agents; Cyclopentanes; Dextromethorphan; Guinea Pigs; Male; Necrosis; Nervous System Diseases; Neurons; Soman | 1990 |